News from amgen A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.
Latest
Sep 20, 2020, 08:39 ET Clinical Data From Full Phase 1 Cohort Of Investigational Sotorasib Published In New England Journal Of Medicine
Amgen (NASDAQ: AMGN) today announced that updated data from the full Phase 1 cohort of the CodeBreaK 100 clinical study, evaluating sotorasib...
Sep 16, 2020, 16:15 ET Amgen To Webcast Investor Calls At ESMO 2020
Amgen (NASDAQ:AMGN) will host two webcast calls for the investment community in conjunction with the European Society for Medical Oncology (ESMO)...
Sep 16, 2020, 16:00 ET Amgen To Showcase Data From Oncology Pipeline During ESMO Virtual Congress 2020
Amgen (NASDAQ:AMGN) announced today that data from its oncology pipeline in solid tumors will be presented during the European Society of Medical...
Sep 15, 2020, 09:00 ET Amgen And MBC BioLabs Announce Winners Of The Amgen Golden Ticket
Amgen (NASDAQ:AMGN) and MBC BioLabs today announced that BigHat Biosciences and Trilo Therapeutics have each been awarded an Amgen Golden Ticket to...
Sep 14, 2020, 16:00 ET Amgen To Present At The 2020 Bank of America Virtual Global Healthcare Conference
Amgen (NASDAQ:AMGN) will present at the Bank of America Virtual Global Healthcare Conference at 12:35 p.m. ET on Thursday, Sept. 17, 2020. Peter H....
Sep 11, 2020, 16:00 ET Amgen To Present At The 18th Annual Morgan Stanley Global Healthcare Conference
Amgen (NASDAQ:AMGN) will present at Morgan Stanley's 18th Annual Virtual Global Healthcare Conference at 11:45 a.m. ET on Wednesday, Sept. 16, 2020....
Sep 04, 2020, 16:00 ET Amgen To Present At The 15th Annual Citi BioPharma Conference
Amgen (NASDAQ:AMGN) will present at Citi's 15th Annual Virtual BioPharma Conference at 2:25 p.m. ET on Thursday, Sept. 10, 2020. Murdo Gordon,...
Aug 29, 2020, 05:31 ET Amgen Announces Positive Data From Phase 3B Study Of Repatha® (Evolocumab) In Pediatric Patients With Heterozygous Familial Hypercholesterolemia At ESC Congress 2020
Amgen (NASDAQ:AMGN) today announced positive data from the HAUSER-RCT Phase 3b study evaluating the safety and efficacy of Repatha® (evolocumab) in...
Aug 25, 2020, 16:00 ET New Amgen Data To Be Presented At ESC Congress 2020 Highlighting Repatha® (evolocumab) Efficacy In High-Risk Patient Populations
Amgen (NASDAQ:AMGN) today announced the presentation of 12 cardiovascular scientific research abstracts, including clinical trial and real-world...
Aug 20, 2020, 17:33 ET FDA Approves New KYPROLIS® (carfilzomib) Combination Regimen With DARZALEX® (daratumumab) And Dexamethasone In Both Once- And Twice-Weekly Dosing Regimens
Amgen (NASDAQ:AMGN) today announced the U.S. Food and Drug Administration (FDA) has approved the expansion of the KYPROLIS® (carfilzomib) U.S....
Aug 13, 2020, 21:52 ET Amgen Announces Pricing Terms For Senior Notes Exchange Offers, Increases The Maximum Notes Exchange Cap And Accepts Tendered Notes
Amgen Inc. (NASDAQ:AMGN) announced today the pricing terms of its previously announced nine separate private offers to exchange (each, an "Exchange...
Aug 13, 2020, 09:00 ET Amgen Announces Early Tender Results Of Senior Notes Exchange Offers
Amgen Inc. (NASDAQ:AMGN) announced today the early tender results of its previously announced nine separate private offers to exchange (each, an...
Aug 06, 2020, 16:32 ET Dia Nacional de Combate ao Colesterol: brasileiros negligenciam as doenças cardiovasculares durante a pandemia
Ficar atento à saúde, principalmente no período de quarentena, é essencial. Incluindo o monitoramento do colesterol, pois se alto, pode ser perigoso. ...
Jul 30, 2020, 07:59 ET Amgen Commences Exchange Offers For Certain Series Of Outstanding Senior Notes From Exchange Eligible Holders
Amgen Inc. (NASDAQ: AMGN) announced today the commencement of nine separate private offers to exchange (each, an "Exchange Offer" and, collectively,...
Jul 28, 2020, 16:01 ET Amgen Reports Second Quarter 2020 Financial Results
Amgen (NASDAQ:AMGN) today announced financial results for the second quarter of 2020. Key results include: Despite the impact of the COVID-19...
Jul 27, 2020, 09:00 ET ANVISA aprova autoinjetor para diminuir exposição hospitalar de pacientes em tratamento oncológico
A ANVISA (Agência Nacional de Vigilância Sanitária) aprovou um autoinjetor, o Neulastim® On-Body Injector (OBI), desenvolvido pela Amgen, uma das...
Jul 23, 2020, 17:00 ET Amgen Announces Webcast Of 2020 Second Quarter Financial Results
Amgen (NASDAQ:AMGN) today announced that it will report its second quarter financial results on Tuesday, July 28, 2020, after the close of the U.S....
Jul 23, 2020, 16:15 ET Amgen Announces 2020 Third Quarter Dividend
Amgen (NASDAQ:AMGN) today announced that its Board of Directors declared a $1.60 per share dividend for the third quarter of 2020. The dividend will...
Jul 23, 2020, 16:00 ET Amgen Appoints Amy E. Miles To Board Of Directors
Amgen today announced the appointment of Amy E. Miles to its Board of Directors, effective July 23, 2020. Ms. Miles will serve as a member of the...
Jul 21, 2020, 09:00 ET Amgen Foundation Awards Khan Academy An Additional $3 Million To Support Science Learning And Educational Equity Amid COVID-19
The Amgen Foundation today announced the renewal of a $3 million grant to Khan Academy to support several key learning initiatives, including virtual ...
Jul 12, 2020, 22:01 ET Amgen Announces Additional Investment In BeiGene
Amgen (NASDAQ:AMGN) today announced an additional investment of approximately $421 million in BeiGene's registered direct offering of ordinary...
Jul 01, 2020, 11:50 ET Appeals Court Affirms Validity Of Enbrel® (etanercept) Patents Injunction Against Sandoz's Infringement Stands
Amgen today announced that the United States Court of Appeals for the Federal Circuit has held in Amgen's favor on the validity of two patents that...
Jun 26, 2020, 11:00 ET Permanecer sem fraturas é essencial para pacientes com osteoporose durante a pandemia
A osteoporose afeta homens e mulheres, geralmente, após os 50 anos. De acordo com a IOF (International Osteoporosis Foundation), a doença é...
Jun 22, 2020, 16:00 ET Amgen Is Supporting Advancement Of AMG 634 For Global Health Diseases In Developing Countries
Amgen (NASDAQ: AMGN) today announced it is supporting the further study of AMG 634, a phosphodiesterase type 4 (PDE4) inhibitor, for the treatment of ...
Jun 18, 2020, 16:00 ET Amgen To Present At The BMO Capital Markets 2020 Prescriptions for Success Healthcare Conference
Amgen (NASDAQ: AMGN) will present at the BMO Capital Markets 2020 Prescriptions for Success Healthcare Conference at 4:00 p.m. ET on Tuesday, June...
